Lucknow, India

Debabrata Chanda


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Debabrata Chanda: Innovator in Anticancer Compounds

Introduction: Debabrata Chanda, based in Lucknow, India, is a notable inventor recognized for his significant contributions to the field of medicinal chemistry. With a focus on the synthesis of novel compounds, Chanda's work aims to address pressing health challenges, particularly in cancer treatment.

Latest Patents: Debabrata Chanda holds a patent for "Benzylidene Indanones and Processes for Preparation and Use Thereof." This innovative invention involves compounds exhibiting tubulin polymerization inhibition, which is critical in cancer research. A key compound in his patent, 2-(3,4-Methylenedioxybenzylidine), 3-(3,4,5-trimethoxyphenyl), 4,5,6-trimethoxyindanone, shows promising anticancer activity and has been synthesized from gallic acid. Evaluations in Swiss albino mice indicated that this compound is safe up to 300 mg/kg body weight and has potent activity, thereby paving the way for the development of new and cost-effective anticancer molecules.

Career Highlights: Chanda's career is rooted in research and innovation within the Council of Scientific & Industrial Research. His commitment to blending scientific rigor with practical applications has garnered attention in the field of medicinal chemistry. His noteworthy patent represents a milestone in developing compounds that could potentially transform cancer treatment.

Collaborations: Throughout his career, Debabrata Chanda has collaborated with esteemed colleagues, including Arvind Singh Negi and Ayyampudur Palanisamy Prakasham. These collaborations enhance the breadth of research and innovation within his projects, contributing to the successful development of his patented inventions.

Conclusion: Debabrata Chanda's work exemplifies the critical intersection of innovation and healthcare. His patent on benzylidene indanones highlights the potential for new therapeutic avenues in cancer treatment. As an integral part of the Council of Scientific & Industrial Research, Chanda continues to push the boundaries of scientific research, showcasing the vital role of inventors in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…